Authors
Loading...
This study demonstrates enhanced neutralizing antibody and T cell responses using antigen multimerization and adjuvants in a SARS-CoV-2 RBD subunit vaccine.
Nunes et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: